Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Sep 01, 2008 (Vol. 28, No. 15)


  • Access to sequences
  • Clunky, ugly
Another offering from The Forsyth Institute, BROP (Bioinformatics Resource for Oral Pathogens), appears to have considerable overlap with the Oral Microbiome site and probably was an earlier version of the same. It is not clear why this one still exists, but such is the way of the Web in many cases. At BROP, one can download databases, sequence tools, and sequence information. There is also a means provided (OPMD) for managing microarray data. This includes options for uploading, analyzing, storing, organizing, and searching. Login is required for access here. Other functions available on the site include ORF genome alignments, a genome explorer, and sequence annotations. The layout here is considerably clunkier (and gaudier) than Forsyth’s other site, so in time (I’m guessing), this one may disappear.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »